tebipenem,
Tebipenem,
161715-21-5,
UNII-Q2TWQ1I31U,
Q2TWQ1I31U,
LJC-11036,
(1R,5S,6S)-6-(1(R)-Hydroxyethyl)-1-methyl-2-(1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl)-1-carba-2-penem-3-carboxylic acid,
(1R,5S,6S)-6-[1(R)-Hydroxyethyl]-1-methyl-2-[1-(2-thiazolin-2-yl)azetidin-3-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid,
CHEMBL576981,
SCHEMBL14769588,
DTXSID40167227,
HY-A0076,
ZINC40721293,
AKOS030526611,
CS-3444,
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-,
BC287750,
SC-53214,
C21522,
185D462,
LJC11036;LJC 11036;LJC-11036,
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,3-[[1-(4,5-dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-, [4R-[4a,5b,6b(R*)]]-,
3-[1-(4,5-Dihydro-thiazol-2-yl)-azetidin-3-ylsulfanyl]-6-(1-hydroxy-ethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid,
Tebipenem [INN],
D0Y6MH,
ACN-040059,
CID9800194,
CID 9800194,
C500135,
158681-13-1,